ChrysCapital closes its continuation fund at $700 million
The new fund has acquired a stake in National Stock Exchange of India Ltd from ChrysCapital's Fund VI
Stay updated with breaking news from Intas Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The new fund has acquired a stake in National Stock Exchange of India Ltd from ChrysCapital's Fund VI
While ChrysCapital aims to raise $2-2.2 billion for its tenth fund, Kedaara is in the market for its fourth fund of $1-1.5 billion
Gujarat-based drugmaker Intas Pharmaceuticals Ltd has had a nearly three-decade-long tryst with private equity investors, having raised capital from ICICI Venture way back in 1996 ......
Innova Captab | The listing was far lower than analysts' expectations and the grey market premium. The expected listing premium was around 25 percent over the issue price.
India Business News: US health regulator issues warning letter to Intas Pharmaceuticals CEO and MD Nimish Chudgar for manufacturing lapses and violation of CGMP regulation